University of North Carolina at Chapel Hill AIDS Clinical Trials Unit — Chapel Hill, North Carolina

University of North Carolina at Chapel Hill AIDS Clinical Trials Unit is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 48/100 (POOR). This profile has not yet been claimed by the site owner.

University of North Carolina at Chapel Hill AIDS Clinical Trials Unit has participated in 1 clinical trials.

Therapeutic areas: Cough, Sore Throat, Nasal Congestion.

Sponsors: BioCryst Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 48/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina at Chapel Hill AIDS Clinical Trials Unit?

University of North Carolina at Chapel Hill AIDS Clinical Trials Unit has a Crixeo Trust Score of 48/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina at Chapel Hill AIDS Clinical Trials Unit conducted?

University of North Carolina at Chapel Hill AIDS Clinical Trials Unit has 1 clinical trials on record. Their work covers Cough, Sore Throat, Nasal Congestion.

Is University of North Carolina at Chapel Hill AIDS Clinical Trials Unit accredited by Crixeo Health?

University of North Carolina at Chapel Hill AIDS Clinical Trials Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina at Chapel Hill AIDS Clinical Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.